TW200400165A - Process for preparing trans-4-aminocylcohexanecarboxylic acids - Google Patents

Process for preparing trans-4-aminocylcohexanecarboxylic acids Download PDF

Info

Publication number
TW200400165A
TW200400165A TW92105567A TW92105567A TW200400165A TW 200400165 A TW200400165 A TW 200400165A TW 92105567 A TW92105567 A TW 92105567A TW 92105567 A TW92105567 A TW 92105567A TW 200400165 A TW200400165 A TW 200400165A
Authority
TW
Taiwan
Prior art keywords
trans
salt
group
scope
cis
Prior art date
Application number
TW92105567A
Other languages
Chinese (zh)
Other versions
TWI280232B (en
Inventor
Masataka Hikota
Yuichi Koga
Original Assignee
Tanabe Seiyaku Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tanabe Seiyaku Co filed Critical Tanabe Seiyaku Co
Publication of TW200400165A publication Critical patent/TW200400165A/en
Application granted granted Critical
Publication of TWI280232B publication Critical patent/TWI280232B/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C227/00Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C227/14Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton from compounds containing already amino and carboxyl groups or derivatives thereof
    • C07C227/16Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton from compounds containing already amino and carboxyl groups or derivatives thereof by reactions not involving the amino or carboxyl groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/09Geometrical isomers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

The present invention provides a process for preparing a trans-4-aminocylcohexanecarboxylic acid or a salt thereof, or an amino-protected derivative of trans-4-aminocylcohexanecarboxylic acid or a salt thereof, which comprises treating a 4-aminocyclohexanecarboxylic acid or a reactive derivative thereof, which is in the cis form or in the form of a cis/trans mixture, with a base selected from the group consisting of a sodium hydroxide and a potassium alkoxide, and protecting the amino group of the product, when necessary.

Description

200400165 五、發明說明(1) 【發明所屬之技術領域】 本發明係有關做為醫藥品之原料化合物等有用之反式 - 4 -胺基環己烷羧酸類之新穎製造方法。詳言之,係有關 由4 -胺基環己烷羧酸之順式異構物或順式與反式異構物之 混合物製造高純度反式異構物之新穎方法。 【先前技術】 反式-4 -胺基環己烷羧酸和其胺基保護衍生物乃係醫 藥、農藥之原料。中間化合物等方面有用之化合物,例如 可供治療糖尿病等使用之二肽基二肽酶I V ( DPP I V )阻礙劑 之原料化合物用途(參考國際專利2 0 0 2 - 3 0 8 9 1號公報)。 製造反式-4 -胺基環己烷羧酸,例如可經由4 -胺基苯 甲酸之催化還原而得之大量且價廉之4 -胺基環己烷羧酸 (反式和順式異構物之混合物)利用再結晶分離法取得反式 異構物之方法[參考J· Medicinal Chemistry,3 6卷, 1 1 0 0至1 1 0 3,( 1 9 9 3年)]。然而,該方法之缺點為所製得 反式異構物之收率極低。 另外,亦可將4 -取代基-環己烷羧酸之吸式異構物或 順式和反式異構物之混合物加以異構化而製得反式異構物 之方法,例如將4 -異丙基-環己烷羧酸加以曱酯化後再於 氮化鈉之共存下加熱之方法(參考歐洲專利第0 1 9 6 2 2 2號公 報),另有將4 -異丙基-環己烷羧酸在氫氧化鈉之共存下加 熱之方法[參考 J. Chemical Society, 1245至 1247, (1 9 3 9年)],還有將4 -取代基-環己烷羧酸鹼金屬鹽或鹼土 金屬鹽加熱之方法(參考特開昭6 0 - 2 5 8 1 4 1號公報),或將200400165 V. Description of the invention (1) [Technical field to which the invention belongs] The present invention relates to a novel method for producing trans-4-aminocyclohexanecarboxylic acids which is useful as a raw material compound for pharmaceuticals and the like. Specifically, it relates to a novel method for producing a high-purity trans isomer from a cis isomer of 4-aminocyclohexanecarboxylic acid or a mixture of cis and trans isomer. [Prior art] Trans-4 -aminocyclohexanecarboxylic acid and its amine-protected derivatives are raw materials of medicines and pesticides. Intermediate compounds and other useful compounds, such as raw material compounds of dipeptidyl dipeptidase IV (DPP IV) inhibitors that can be used in the treatment of diabetes, etc. (refer to International Patent No. 2002-3 0 8 9 1) . Production of trans-4 -aminocyclohexanecarboxylic acid, for example, a large amount of inexpensive 4-aminocyclohexanecarboxylic acid (trans and cis-iso A mixture of structures) A method for obtaining trans isomers by recrystallization separation method [Ref. J. Medicinal Chemistry, Vol. 36, 1 1 0 to 1 10 3, (1933 years)]. However, this method has the disadvantage that the yield of the trans isomers obtained is extremely low. In addition, the method of preparing isomers of 4-substituent-cyclohexanecarboxylic acid isomers or mixtures of cis and trans isomers may be used, for example, 4 -Isopropyl-cyclohexanecarboxylic acid is esterified with ethyl acetate and then heated in the coexistence of sodium nitride (refer to European Patent No. 0 1 9 6 2 2), and 4-isopropyl -A method of heating cyclohexanecarboxylic acid in the coexistence of sodium hydroxide [Ref. J. Chemical Society, 1245 to 1247, (1939)], and a 4-substituent-cyclohexanecarboxylic acid base A method for heating a metal salt or an alkaline earth metal salt (refer to JP 6 0-2 5 8 1 41), or

314510.ptd 第5頁 200400165 五、發明說明(2) 4 -取代基-環己烧魏酸加熱之方法(參考特開昭5 6 - 1 2 0 6 3 6 號公報,特開昭5 6 - 1 2 5 3 4 2號公報)等周知方法。這些方法 皆屬利用可溶解基質或生成物之溶劑(例如水、醇類等)或 &不使用溶劑而以基質或生成物本身兼為溶劑而在均一系 〆即溶液狀態)進行異構化反應之方法。由於這些方法所得 反式異構物之比率偏低,所以必須再進行煩雜之精製操作 始能獲得高純度之反式異構物。 另外,特開平1 0 - 2 3 7 0 1 5號公報中記載有將4 -位置為 烷基、氟化烷基或羧基之環己烷羧酸或其活性衍生物在氫 •化鉀之共存下加熱而行異構化之方法。然而將該方法應 用在4 -胺基環己烷羧酸時,發現其缺點為需要長時間之反 應。 換言之,以上述已往方法做為不含順式異構物之高純 度反式-4-胺基環己烷羧酸類之製法時,效率不佳,極希 望研究開發更優良方法。 【發明内容】 本發明之目的在提供反式-4 -胺基環己烷羧酸類之高 效率而優異之製造方法。詳言之,本發明提供由4 -胺基環 己烷羧酸或其活性衍生物之順式異構物或順式和反式異構 IP之混合物高效率地製造高純度反式異構物之方法。 • 本發明研究者為解決上述問題,經積極努力研究之結 果,發現使用廉價的氫氧化鈉或烷醇鉀可將4 -胺基環己烷 羧酸之順式異構物或順式和反式異構物之混合物非常有效 率地異構化而生成反式異構物。亦即,發現利用該鹼,可314510.ptd Page 5 200400165 V. Explanation of the invention (2) 4-Substituent method for heating cyclohexanylweiric acid (refer to JP 5 6-1 2 0 6 3 6 and JP 5 6- 1 2 5 3 4 2) and other well-known methods. These methods are all isomerization using a solvent (such as water, alcohols, etc.) that can dissolve the matrix or the product, or & without using a solvent, and the matrix or the product itself serves as a solvent in a homogeneous state (that is, a solution state). Method of reaction. Since the ratio of trans isomers obtained by these methods is relatively low, complicated purification operations must be performed again to obtain high purity trans isomers. In addition, Japanese Patent Application Laid-Open No. 10-2 3 7 0 1 5 describes the coexistence of a cyclohexanecarboxylic acid or an active derivative thereof having an alkyl group, a fluorinated alkyl group, or a carboxyl group at a 4-position in the presence of potassium hydroxide Method of isomerization under heating. However, when this method was applied to 4-aminocyclohexanecarboxylic acid, it was found that the disadvantage was that it required a long reaction time. In other words, when the above-mentioned conventional method is used as a method for preparing a high-purity trans-4-aminocyclohexanecarboxylic acid without cis isomer, the efficiency is not good, and it is highly desirable to research and develop a better method. SUMMARY OF THE INVENTION An object of the present invention is to provide a highly efficient and excellent manufacturing method of trans-4 -aminocyclohexanecarboxylic acids. Specifically, the present invention provides the efficient production of high-purity trans isomers from cis isomers of 4-aminocyclohexanecarboxylic acids or their reactive derivatives, or mixtures of cis and trans isomers IP. Method. • In order to solve the above problems, the researcher of the present invention has researched actively and found that using cheap sodium hydroxide or potassium alkoxide can convert the cis isomer or cis and trans of 4-aminocyclohexanecarboxylic acid. Mixtures of formula isomers are isomerized very efficiently to form trans isomers. That is, it was found that with this base, it is possible to

314510.ptd 第6頁 200400165 五、發明說明(3) 以在短時間之反應製成高純度之反式-4 -胺基環己烷羧酸 之方法。必要時,在異構化反應後之生成物之胺基上加以 保護基,發現更能獲得純度佳之反式異構物而完成了本發 明。 本發明之特徵為將4 -胺基環己烷羧酸或其活性衍生物 之順式異構物或順式和反式異構物之混合物使用選擇自氫 氧化納和烧醇钟所構成群中之驗處理,必要時在所得生成 物之胺基上加以保護基而製成反式-4 -胺基環己烷羧酸或 其鹽,或反式-4 -胺基環己烷羧酸之胺基保護衍生物或其 鹽之製法。 【實施方式】 4 -胺基環己烷羧酸之活性衍生物係指本發明之異構化 反應所使用氫氧化鈉或烷醇鉀之共存下脫離保護基而能變 換成羧酸之羧酸保護衍生物。4 -胺基環己烷羧酸之活性衍 生物之具體例舉為4 -胺基環己烷羧酸酯(例如曱酯、乙酯 等之低級烷酯或苯曱酯、對-硝基苯曱酯、二苯甲基酯、 三苯曱基酯、蒽基曱酯等之可具有取代基之芳基低級烷基 酯等)等。 本發明之異構化反應中,鹼係使用氫氧化鈉或烷醇 鉀。烷醇鉀之例舉如第三丁醇鉀、乙醇鉀、曱醇鉀等。 本發明之異構化反應中所使用之鹼以氫氧化鈉和第三 丁醇鉀為較佳,尤以氫氧化納為最佳。 本發明之異構化反應中所使用之氫氧化鈉或烷醇鉀之 用量,對於4 -胺基環己烷羧酸或其活性衍生物計,通常為314510.ptd Page 6 200400165 V. Description of the invention (3) A method for preparing high-purity trans-4 -aminocyclohexanecarboxylic acid by reaction in a short time. If necessary, a protective group is added to the amine group of the product after the isomerization reaction, and it is found that a trans isomer having a higher purity can be obtained, and the present invention has been completed. The present invention is characterized in that the cis isomer or a mixture of cis and trans isomers of 4-aminocyclohexanecarboxylic acid or its active derivative is selected from the group consisting of sodium hydroxide and alcohol In the test process, if necessary, a protective group is formed on the amine group of the resulting product to make trans-4 -aminocyclohexanecarboxylic acid or a salt thereof, or trans-4 -aminocyclohexanecarboxylic acid. A method for preparing an amino-protected derivative or a salt thereof. [Embodiment] An active derivative of 4-aminocyclohexanecarboxylic acid refers to a carboxylic acid that can be converted into a carboxylic acid by removing the protective group in the coexistence of sodium hydroxide or potassium alkoxide used in the isomerization reaction of the present invention. Protect derivatives. Specific examples of the active derivative of 4-aminocyclohexanecarboxylic acid are 4-aminocyclohexanecarboxylic acid esters (e.g., lower alkyl esters or phenylacetates of p-esters, ethyl esters, etc., p-nitrobenzene). An aryl lower alkyl ester which may have a substituent, such as a fluorenyl ester, a benzyl ester, a triphenyl fluorenyl ester, an anthryl fluorenyl ester, etc.). In the isomerization reaction of the present invention, sodium hydroxide or potassium alkoxide is used as the base. Examples of potassium alkoxides include potassium tert-butoxide, potassium ethoxide, potassium alkoxide, and the like. The base used in the isomerization reaction of the present invention is preferably sodium hydroxide and potassium tert-butoxide, and most preferably sodium hydroxide. The amount of sodium hydroxide or potassium alkoxide used in the isomerization reaction of the present invention is usually based on 4-aminocyclohexanecarboxylic acid or its active derivative.

第7頁 314510.ptd 200400165 五、發明說明(4) 2至1 0當量範圍,其中以2至3當量為較佳,最佳為2當量。 本發明之異構化反應中,使用氫氧化鈉為鹼時,產生 反式-4 -胺基環己烷羧酸鈉,又,使用烷醇鉀為鹼時,產 **生反式-4 -胺基環己烧魏酸鉀。 ^ 本發明之異構化反應所得之反式-4 -胺基環己烷羧酸 之鈉鹽或鉀鹽,必要時可轉換成游離之反式-4 -胺基環己 _烷羧酸或其他鹽類(例如鋰鹽、鎂鹽、鈣鹽、鋇鹽、鋅 鹽、鋁鹽等)。上述轉換可藉周知常用方法而實施。 換言之,依照本發明可製得反式-4 -胺基環己烷羧酸 ®其鹽類(例如納鹽、钟鹽、鐘鹽、鎮鹽、妈鹽、鋇鹽、 鋅鹽、鋁鹽等)。 該異構化反應通常在1 0 0至2 5 0°C範圍進行,其中以 1 5 0至2 4 0°C範圍實施為較佳。又,使用氫氧化鈉進行鹼處 理時,較好在1 7 0至2 4 0°C範圍,使用烷醇鉀處理時軚好在 1 5 0至2 2 0°C之範圍實施。 本異構化反應中,尤以隨反應之進行,變成固體-液 體之不均一系的條件下反式為宜。換言之,所產生之反式 -4 -胺基環己烷羧酸之鹽雖然少,但至少一部分以固體存 在,且所產生之順式-4 -胺基環己烷羧酸之鹽不呈固體而 溶解或熔融狀態存在之條件下進行反應為佳。在上述條 、件下實施本異構化反應時,所產生之反式異構物之至少一 部分變成固體而析出反應體系之外,另一方面,順式異構 ~物以溶解或熔融狀態留存在反應體系内,所以熱力學上之 .平衡狀態偏向於反式異構物之一方。因此,向反式異構物Page 7 314510.ptd 200400165 V. Description of the invention (4) The range of 2 to 10 equivalents, of which 2 to 3 equivalents is better, and the best is 2 equivalents. In the isomerization reaction of the present invention, when sodium hydroxide is used as a base, sodium trans-4 -aminocyclohexanecarboxylate is produced, and when potassium alkoxide is used as a base, trans-4 is produced. -Potassium aminocyclohexanoate. ^ The sodium or potassium salt of trans-4 -aminocyclohexanecarboxylic acid obtained by the isomerization reaction of the present invention can be converted into free trans-4 -aminocyclohexane-carboxylic acid or Other salts (such as lithium, magnesium, calcium, barium, zinc, aluminum, etc.). The above conversion can be implemented by a well-known and commonly used method. In other words, according to the present invention, trans-4 -aminocyclohexanecarboxylic acid® salts (such as sodium salt, bell salt, bell salt, ballast salt, mother salt, barium salt, zinc salt, aluminum salt, etc. ). The isomerization reaction is usually carried out in the range of 100 to 250 ° C, and it is more preferable to implement it in the range of 150 to 240 ° C. When alkali treatment is performed using sodium hydroxide, it is preferably performed in a range of 170 to 240 ° C, and when treated with potassium alkoxide, it is preferably performed in a range of 150 to 220 ° C. In the present isomerization reaction, the trans form is particularly suitable under the condition that the reaction proceeds to a heterogeneous solid-liquid system. In other words, although the amount of the salt of trans-4 -aminocyclohexanecarboxylic acid is small, at least a part of it is present as a solid, and the salt of cis-4 -aminocyclohexanecarboxylic acid is not solid The reaction is preferably performed in the presence of a dissolved or molten state. When the isomerization reaction is carried out under the conditions described above, at least a part of the trans isomers produced becomes solid and precipitates out of the reaction system. On the other hand, the cis isomers remain in a dissolved or molten state. In the reaction system, the thermodynamic equilibrium state is biased towards one of the trans isomers. Therefore, the trans isomers

3145]〇.ptd 第8頁 200400165 五、發明說明(5) 之異構化得順利進行,因而提升反式異構物之產生比率。 本異構化反應可在溶劑中進行,該溶劑以使用在進行 本異構化反應之溫度下,所產生之反式-4 -胺基環己烷羧 酸之鹽至少有一部分能以固體而存在,且所產生之順式 -4 -胺基環己烷羧酸之鹽不形成固體而以溶解或熔融狀態 存在之溶劑種類為宜。 上述溶劑可例舉如二曱苯(鄰-二曱苯、間-二曱苯、 對-二曱苯以及其混合物等),均三曱苯、曱基異丙基苯 (鄰-曱基異丙基苯、間-曱基異丙基苯、對-甲基異丙基苯 以及其混合物等),萘烷(反式-萘烧、順式-萘烧和其混合 物等)、萘、癸烧、Η--碳烷、十二碳烧、十二碳烯、聯 苯等碳原子數8以上之碳氫化合物、二乙二醇二曱醚、苯 曱醚、二乙二醇二乙醚、三乙二醇二曱醚、二苯基醚等碳 原子數6以上之醚類、三丁胺、三苯基胺等碳原子數8以上 之胺類以及其混合物等。 其中以碳原子數8以上之碳氫化合物、碳原子數6以上 之醚、以及其混合物為較佳,尤以二曱苯(鄰-二甲苯、間 -二曱笨、對-二曱苯和其混合物等)、均三曱基苯、曱基-異丙基苯(鄰-曱基異丙基苯、間-曱基-異丙基苯、對-曱 基異丙基苯、以及其混合物等),萘烷(反式-萘烷、順式- 萘烷,以及其混合物等)、萘、癸烷、Η--碳烧、十二碳 烧、聯苯、二乙二醇二曱醚、二乙二醇二乙醚、二苯基驗 以及其混合物為更佳。特別是均三曱基苯、曱基異丙基苯 (鄰-曱基異丙基苯、間-曱基異丙基苯、對-曱基異丙基苯3145]. Ptd page 8 200400165 V. Description of the invention (5) The isomerization proceeded smoothly, thus increasing the production rate of trans isomers. The present isomerization reaction can be carried out in a solvent. The solvent is used at a temperature at which the isomerization reaction is performed, and at least a part of the salt of the trans-4 -aminocyclohexanecarboxylic acid can be solid. The kind of solvent which is present and the cis-4-aminocyclohexanecarboxylic acid salt produced does not form a solid but exists in a dissolved or molten state. The above solvents may be exemplified by di-xylene (o-xylene, m-xylene, p-xylene, mixtures thereof, etc.), mesitylene, fluorenyl isopropylbenzene (o-xylene) Propylbenzene, m-fluorenylisopropylbenzene, p-methylisopropylbenzene and mixtures thereof), decalin (trans-naphthalene, cis-naphthalene and mixtures thereof, etc.), naphthalene, decyl Burning, thorium--carbane, dodecane burning, dodecene, biphenyl, and other hydrocarbons having 8 or more carbon atoms, diethylene glycol dimethyl ether, phenyl ether, diethylene glycol diethyl ether, Ethers having 6 or more carbon atoms, such as triethylene glycol dimethyl ether and diphenyl ether; amines having 8 or more carbon atoms, such as tributylamine and triphenylamine; and mixtures thereof. Among them, hydrocarbons having 8 or more carbon atoms, ethers having 6 or more carbon atoms, and mixtures thereof are preferred, and xylene (o-xylene, m-xylene, p-xylene, and Mixtures thereof), mesitylene, fluorenyl-isopropylbenzene (o-fluorenyl cumene, m-fluorenyl-cumene, p-fluorenyl cumene, and mixtures thereof) Etc.), decalin (trans-naphthyl, cis-naphthyl, and mixtures thereof, etc.), naphthalene, decane, fluorene-carbon, dodecyl, diphenyl, diethylene glycol difluorene ether , Diethylene glycol diethyl ether, diphenyl ether and mixtures thereof are more preferred. In particular, mesitylene, cumene isopropylbenzene (o-fluorenyl cumene, m-fluorenyl cumene, p-fluorenyl cumene

314510.ptd 第9頁 200400165 五、發明說明(6) 以及其混合物等桌烧(反式-桌烧、順式-桌烧以及其混 合物等)、十二碳烷、二乙二醇二乙醚以及其混合物為最 佳。 • 使用氫氧化鈉作為鹼時,所用溶劑以反應條件下安定 、且反式-4 -胺基環己烷羧酸之鈉鹽能以固體存在,同時順 式-4 -胺基環己烷羧酸之鈉鹽不會形成固體而能溶解或以 熔融狀態存在者為宜,此種溶劑可例舉如二曱苯(鄰-二曱 苯、間-二曱苯、對-二曱苯以及其混合物等)、均三曱基 苯、曱基異丙基苯(鄰-曱基異丙基苯、間-曱基異丙基 籲、對-曱基異丙基苯以及其混合物等)、萘烷(反式-萘 烷、順式-萘烧以及其混合物等),萘、癸烧、Η--碳烧、 十二碳烧、十二碳烯、聯苯等碳原子數8以上之碳氫化合 物、二乙二醇二曱醚、苯曱醚、二乙二醇二乙醚、三乙二 醇二曱醚、二苯基醚等碳原子數6以上之醚、三丁胺、三 苯基胺等碳原子數8以上之胺以及其混合物等。其中以沸 點在1 8 0°C以上者更佳,此種溶劑可例舉如萘烷(反式-萘 烷、順式-萘烧以及其混合物等)、萘、Η--碳烧、十二碳 烷、十二碳烯、聯笨、二乙二醇二乙醚、三乙二醇二曱 醚、二苯基醚、三丁胺、三苯基胺和其混合物等。其中以 费烧(反式-蔡纟完、順式-蔡烧以及其混合物等)、蔡、十一 碳烷、十二碳烷、聯苯、二乙二醇二乙醚、三乙二醇二曱 鱗、二苯基鱗以及其混合物為更佳’尤以桌烧(反式-桌 烧、順式-萘烧以及其混合物等)、十二碳烧、二乙二醇二 乙鱗以及其混合物為最佳。314510.ptd Page 9 200400165 V. Description of the invention (6) and its mixtures such as table-fired (trans-table-fired, cis-table-fired and mixtures thereof), dodecane, diethylene glycol diethyl ether, and Its mixture is optimal. • When using sodium hydroxide as a base, the solvent used is stable under the reaction conditions, and the sodium salt of trans-4 -aminocyclohexanecarboxylic acid can exist as a solid, while cis-4 -aminocyclohexanecarboxylic acid The sodium salt of the acid does not form a solid and can be dissolved or exists in a molten state. Such a solvent may be exemplified by dibenzobenzene (o-diphenylbenzene, m-diphenylbenzene, p-diphenylbenzene, and others). Mixture, etc.), mesitylene, isopropyl isopropylbenzene (o-fluorenyl isopropylbenzene, m-fluorenyl isopropyl, p-fluorenyl isopropylbenzene, and mixtures thereof), naphthalene (Trans-naphthene, cis-naphthalene, and mixtures thereof), naphthalene, decane, fluorene-carbon, dodecyl, dodecene, biphenyl, and other carbon atoms having a carbon number of 8 or more Hydrogen compounds, diethylene glycol dimethyl ether, phenyl ether, diethylene glycol diethyl ether, triethylene glycol dimethyl ether, diphenyl ether, ethers having 6 or more carbon atoms, tributylamine, triphenyl Amines having 8 or more carbon atoms, such as amines, and mixtures thereof. Among them, a boiling point above 180 ° C is more preferable. Examples of such solvents include decalin (trans-decalin, cis-naphthalene, and mixtures thereof), naphthalene, fluorene-carbon, and Dioxane, dodecene, bibenzyl, diethylene glycol diethyl ether, triethylene glycol dimethyl ether, diphenyl ether, tributylamine, triphenylamine, and mixtures thereof, and the like. Among them are Firing (trans-Cai Weiwan, cis-Cai burning and mixtures thereof), Tsai, undecane, dodecane, biphenyl, diethylene glycol diethyl ether, triethylene glycol di曱 scales, diphenyl scales, and mixtures thereof are more preferred, especially table-fired (trans-table-fired, cis-naphthalene-fired and mixtures thereof), twelve-carbon fired, diethylene glycol diethyl scale, and others Mixtures are optimal.

314510.ptd 第10頁 200400165 五、發明說明(7) 使用烷醇鉀作為鹼時,所用溶劑以反應條件下安定且 反式-4 -胺基環己烷羧酸之鉀鹽能以固體存在,同時順式 -4 -胺基環己烷羧酸之鉀鹽不會形成固體而能溶解或以熔 解狀態存在者為宜,此種溶劑可例舉如二甲苯(鄰-二甲 苯、間-二曱苯、對-二曱苯以及其混合物等)、均三曱基 苯、曱基異丙基苯(鄰-曱基異丙基苯、間-曱基異丙基 苯、對-曱基異丙基苯以及其混合物等)、萘烷(反式-萘 烷、順式-萘烷以及其混合物等)、萘、癸烧、十一碳烷、 十二碳烷、十二碳烯、聯苯等碳原子數8以上之碳氫化合 物、二乙二醇二曱醚、苯曱謎、二乙二醇二乙_、三乙二 醇二甲醚、二苯基醚等碳原子數6以上之醚、三丁胺、三 苯基胺等碳原子數8以上之胺以及其混合物等。其中以沸 點在1 6 0°C以上者更佳。此種溶劑可例舉如均三甲基苯、 曱基異丙基苯(鄰-曱基異丙基笨、間-甲基異丙基苯、對-曱基異丙基苯以及其混合物等)、萘烷(反式-萘烷、順式-桌烧以及其混合物等)、蔡、癸烧、十一碳烧、十二碳 烷、十二碳烯、聯苯、二乙二醇二曱醚、二乙二醇二乙 醚、三乙二醇二曱醚、二笨基醚、三丁胺、三苯基胺和其 混合物等。其中以均三曱基苯、曱基異丙基苯(鄰-曱基異 丙基苯、間-甲基異丙基苯、對-曱基異丙基苯以及其混合 物等),萘烷(反式-萘烷、順式-萘烷以及其混合物等)、 蔡、癸烷、Η——碳烷、十二碳烷、聯苯、二乙二醇二曱 醚、二乙二醇二乙醚、二苯基醚以及其混合物為更佳。尤 以均三曱基苯、曱基異丙基苯(鄰-甲基異丙基苯、間-甲314510.ptd Page 10 200400165 V. Description of the invention (7) When potassium alkoxide is used as the base, the solvent used is stable under the reaction conditions and the potassium salt of trans-4 -aminocyclohexanecarboxylic acid can exist as a solid. At the same time, the potassium salt of cis-4-aminocyclohexanecarboxylic acid does not form a solid and can be dissolved or exists in a molten state. This solvent can be exemplified by xylene (o-xylene, m-xylene Benzene, p-diphenylbenzene and mixtures thereof, etc.), mesitylene, cumene isopropylbenzene (o-fluorenyl cumene, m-fluorenyl cumene, p-fluorenyl isopropyl Propylbenzene and mixtures thereof, etc.), decalin (trans-naphthane, cis-naphthane and mixtures thereof, etc.), naphthalene, decane, undecane, dodecane, dodecene, biphenyl Hydrocarbons having 8 or more carbon atoms, such as benzene, diethylene glycol dimethyl ether, benzene diazepam, diethylene glycol diethyl ether, triethylene glycol dimethyl ether, diphenyl ether, etc. Amines having 8 or more carbon atoms, such as ethers, tributylamine, and triphenylamine, and mixtures thereof. Among them, those with a boiling point above 160 ° C are more preferred. Examples of such a solvent include mesitylene, fluorenyl isopropylbenzene (o-fluorenyl isopropylbenzene, m-methyl cumene, p-fluorenyl cumene, and mixtures thereof). ), Decalin (trans-naphthyl, cis-table, and mixtures thereof), Tsai, decane, undecyl, dodecane, dodecene, biphenyl, diethylene glycol Dimethyl ether, diethylene glycol diethyl ether, triethylene glycol dimethyl ether, dibenzyl ether, tributylamine, triphenylamine, and mixtures thereof. Among them, mesitylene, isopropyl isopropylbenzene (o-isopropyl isopropylbenzene, m-methylisopropylbenzene, p-isopropylisopropylbenzene, and mixtures thereof), decalin ( Trans-naphthane, cis-naphthane and mixtures thereof, etc.), Tsai, decane, hydrazone—carbane, dodecane, biphenyl, diethylene glycol dimethyl ether, diethylene glycol diethyl ether , Diphenyl ether and mixtures thereof are more preferred. In particular, mesitylene, isopropyl isopropylbenzene (o-methyl cumene, m-methyl

314510.ptd 第11頁 200400165 五、發明說明(8) 基異丙基苯、對-曱基異丙基苯以及其混合物等),萘烷 (反式-萘烧、順式-萘烷以及其混合物等)、十二碳烷、二 乙二醇二乙醚以及其混合物為最佳。 ^ 本異構化反應在常壓或加壓下可順利進行,其中以常 壓至3氣壓下實施為較佳,尤以常壓下實施為更佳。 又,本異構化反應可藉常用方法,例如高效率液態層 >析法(HPLC)、薄層層析法(TLC)等分析方法監視反應之終 點,反應通常在6至30小時結束,其中以6至2 4小時終結反 應為較佳。 # 本發明中,以氫氧化鈉或烷醇鉀進行異構化反應之 後,必要時可在生成物之胺基上進行保護基之加成反應 (下文中,稱為胺基保護反應)而製成反應異構物(即,反 式-4 -胺基環己烷羧酸之胺基保護衍生物)。 反式-4 -胺基環己烧叛酸之胺基保護衍生物較之順式 異構物,其結晶性佳。利用此種特性可有效率地分離取得 更高純度之反式異構物。換言之,將所得胺基保護衍生物 按照一般方法結晶化之後分離、洗淨,較之按照一般方法 再結晶化之後分離、洗淨、更能提升反式異構物之純度。 進行胺基保護反應時,可使用由異構化反應所製得之 眷式-4 -胺基環己烷羧酸之鈉鹽或鉀鹽,或按照一般方法 •將上述轉換成為遊離之反式-4 -胺基環己烷羧酸或其他鹽 類(例如鋰鹽、鎂鹽、鈣鹽、鋇鹽、鋅鹽、鋁鹽等)之後, —提供胺基保護反應用途。 . 又,異構化反應所製得反式-4 -胺基環己烷羧酸之鈉314510.ptd Page 11 200400165 V. Description of the invention (8) Isopropylbenzene, p-fluorenylisopropylbenzene and mixtures thereof), decalin (trans-naphthyl, cis-naphthyl and its Mixtures, etc.), dodecane, diethylene glycol diethyl ether, and mixtures thereof are most preferred. ^ The isomerization reaction can be carried out smoothly under normal pressure or pressure. Among them, it is better to carry out under normal pressure to 3 atm, especially to carry out under normal pressure. In addition, the isomerization reaction can be monitored by common methods such as high-efficiency liquid layer analysis (HPLC), thin-layer chromatography (TLC) and other analytical methods. The reaction usually ends in 6 to 30 hours. It is more preferable to terminate the reaction in 6 to 24 hours. # In the present invention, after the isomerization reaction with sodium hydroxide or potassium alkoxide, if necessary, a protective group addition reaction (hereinafter, referred to as an amine protection reaction) can be prepared on the amine group of the product. Into reactive isomers (ie, amine-protected derivatives of trans-4 -aminocyclohexanecarboxylic acid). The amino protected derivative of trans-4 -aminocyclohexanoic acid is more crystalline than the cis isomer. With this feature, trans isomers with higher purity can be efficiently separated. In other words, separating and washing the obtained amine-protected derivative after crystallization according to a general method can improve the purity of the trans isomer more than separating and washing after recrystallization according to a general method. When carrying out the amine-protection reaction, the sodium or potassium salt of the dependent formula-4 -aminocyclohexanecarboxylic acid prepared by the isomerization reaction can be used, or the above can be converted into the free trans-form according to the general method -4-After aminocyclohexanecarboxylic acid or other salts (such as lithium salt, magnesium salt, calcium salt, barium salt, zinc salt, aluminum salt, etc.),-to provide the use of amine protection reaction. Also, the sodium of trans-4 -aminocyclohexanecarboxylic acid prepared by the isomerization reaction

314510.ptd 第12頁 200400165 五、發明說明(9) 鹽或鉀鹽,或其轉換後所得遊離之反式-4 -胺基環己烷羧 鹽或其他鹽類,可在分離後提供胺基保護反應用途,也可 在不經分離之情況下直接將含有該化合物之溶液等提供胺 基保護反應用途。 胺基之保護基可採用例如可具有取代基之低級烷氧基 羰基,低級烷醯基、芳醯基等,具體言之,例如苯曱氧基 羰基、4-曱氧基苯曱氧基羰基、9-芴基曱氧基羰基、第三 丁氧基羰基、2, 2, 2-三氯乙基氧基羰基、曱醯基、乙醯 基、丙醯基、丁醯基、苯曱醯基等。其中以可具有取代基 之低級烷氧基羰基為較佳,尤以苯曱基氧基羰基和第三丁 氧基魏基為更佳。 胺基之保護基加成以苯甲基氧基羰基時,反式-4 -胺 基環己烷羧酸之胺基保護衍生物可製得反式-4 -(苯曱基氧 羰基胺基)環己烷羧酸。 本發明中之胺基保護反應可按照一般方法實施。 例如胺基上加成以苯曱基氧基羰基之反應,可在溶劑 中,於鹼之共存下,和苯曱基氧基羰基鹵化物反應而進 行。溶劑祇要是不影響反應就可使用,例如水、曱醇、乙 醇等可供採用。鹼可採用氫氧化鈉、氫氧化鉀、碳酸鉀 等。苯曱基氧基羰基i化物以苯曱基氧基羰基氯化物為較 適用。本反應在-4 0°C至1 0 0°C範圍進行,其中以0°C至室 溫更可順利進行。 又,例如胺基上加成以第三丁氧基羰基之反應,可在 溶劑中,於鹼之共存下,和二第三丁基二碳酸酯反應而實314510.ptd Page 12 200400165 V. Description of the invention (9) Salt or potassium salt, or the free trans-4 -aminocyclohexane carboxylate or other salt obtained after conversion, can provide amine group after separation For protection reaction, the solution containing the compound can also be used for protection reaction of amine group without isolation. The protective group for the amine group may be, for example, a lower alkoxycarbonyl group, a lower alkylfluorenyl group, an arylfluorenyl group, etc. which may have a substituent, and specifically, for example, a phenylfluorenyl carbonyl group, a 4-fluorenylphenoxy group , 9-fluorenylfluorenyloxycarbonyl, third butoxycarbonyl, 2, 2, 2-trichloroethyloxycarbonyl, fluorenyl, ethylfluorenyl, propylfluorenyl, butylfluorenyl, phenylfluorenyl, etc. . Among them, a lower alkoxycarbonyl group which may have a substituent is more preferable, and a phenylfluorenyloxycarbonyl group and a third butoxyweil group are more preferable. When the protective group of amine group is added with benzyloxycarbonyl group, the amine protected derivative of trans-4 -aminocyclohexanecarboxylic acid can be used to prepare trans-4-(phenylfluorenyloxycarbonylamino group). ) Cyclohexanecarboxylic acid. The amine group protection reaction in the present invention can be carried out according to a general method. For example, the addition of a phenylfluorenyloxycarbonyl group to an amino group can be carried out by reacting with a phenylfluorenyloxycarbonyl halide in the presence of a base in a solvent. The solvent can be used as long as it does not affect the reaction. For example, water, methanol, and ethanol can be used. Examples of the alkali include sodium hydroxide, potassium hydroxide, and potassium carbonate. As the phenylfluorenyloxycarbonyl iide, phenylfluorenyloxycarbonyl chloride is more suitable. The reaction is carried out at a temperature range of -40 ° C to 100 ° C, and it can proceed smoothly from 0 ° C to room temperature. In addition, for example, the reaction of addition of a third butoxycarbonyl group to an amine group can be carried out in a solvent in the presence of a base in the presence of a base.

314510.ptd 第13頁 200400165 五 、發明說明 (10) 施 〇 溶 劑 祇 要 不 影 響 反 應 就 可採用 ,例如水、 、曱醇、乙 醇 等 〇 驗 可 採 用 氫 氧 化 鈉 氫 氧化鉀 等。本反應可在-2 0 °c 至 4 0°C 範 圍 進 行 , 尤 以 o°c至室溫下實施為更 佳。 本 發 明 中 所 得 反 式 - 4 -胺基環己烷羧酸之胺 基保護衍 生 物 可 經 結 晶 化 > 分 離 、 洗 淨 、必要 時再結晶後分離、洗 淨 而 單 離 Λ 精 製 之 0 洗 淨 結 晶 可使用 二異丙醚、 >己烧、乙 乙 酸 乙 酯 等 溶 劑 其 中 以 二異丙 醏為最佳c ^又’結晶 化 和 再 結 晶 化 之 分 離 、 精 製 操 作可按 照一般方法進行,尤 其 採 用 碾 製 操 作 為 最 佳 〇 • 本 發 明 所 得 反 式 -4 -胺基環己烷羧酸之胺基 保護衍生 物 , 必 要 時 可 轉 換 成 為 其 鹽 類 (例如納鹽、4甲鹽 、鋰鹽、 鎂 鹽 鹽 鋇 鹽 Λ 鋅 鹽 Λ 鋁 鹽等)< 。該轉換可 按照一般 方 法 實 施 〇 換 言 之 按 昭 本 發 明 可 製 得反式 _ 4 -胺基環 己烷羧酸 之 胺 基 保 護 衍 生 物 或 其 鹽 類 (例如納鹽、_鹽、 鋰鹽、鎂 鹽 鈣 鹽 Λ 鋇 鹽 鋅 鹽 鋁 鹽 等)。 又 , 本 發 明 之 原 料 化 合 物 可使用 市販之4 -胺基環己烷 羧 酸 或 其 活 性 衍 生 物 之 順 式 異 構物或 順式和反式異構物之 混 合 物 〇 又 y 4- -胺 基 環 己 烧 羧 酸之順 式和反式異構物之混 f 物 可 參 考 文 獻 [iH ^ Or gar 1 i c :Syntheses Coll e c t i v e Vo 1 um( 3 Vo : 1 . 5. 6 7 0至 672 ( 1 9 7 3年: ),J . Cherr l i ca 1 S o c : i e' ty Ρ( 3 r 1 (in r Γ r a n s a c t i l ons I ? 1199至 1 20 1 (1 9 7 6年) 等 ]所記載方法; ,由4 -胺基苯曱酸進行催化還原 等已知方 法 而 製 成 〇314510.ptd Page 13 200400165 V. Description of the invention (10) Solvents can be used as long as they do not affect the reaction, such as water, methanol, ethanol, etc. Sodium hydroxide, potassium hydroxide, etc. can be used for testing. This reaction can be carried out in the range of -20 ° C to 40 ° C, and it is more preferably carried out at 0 ° C to room temperature. The amine-protected derivative of trans-4-aminocyclohexanecarboxylic acid obtained in the present invention can be crystallized > isolated, washed, recrystallized if necessary, separated, washed and isolated separately. For the net crystallization, diisopropyl ether, > hexane, ethyl acetate and other solvents can be used. Among them, diisopropylamidine is the best. The separation and purification of crystallization and recrystallization can be performed according to general methods. In particular, it is best to use a milling operation. The amine-protected derivative of trans-4 -aminocyclohexanecarboxylic acid obtained in the present invention can be converted into its salt (such as sodium salt, 4methyl salt, lithium, etc.) if necessary. Salt, magnesium salt, barium salt Λ zinc salt Λ aluminum salt, etc.) < This conversion can be carried out according to a general method. In other words, according to the present invention, an amine-protected derivative of trans-4-aminocyclohexanecarboxylic acid or a salt thereof (e.g., sodium salt, lithium salt, lithium salt, magnesium Salt calcium salt Λ barium salt zinc salt aluminum salt etc.). In addition, as the raw material compound of the present invention, a commercially available cis-isomer of 4-aminocyclohexanecarboxylic acid or an active derivative thereof or a mixture of cis- and trans-isomers can be used. The mixture of cis and trans isomers of cyclohexyl carboxylic acid can be referred to in the literature [iH ^ Or gar 1 ic: Syntheses Coll ective Vo 1 um (3 Vo: 1. 5. 6 7 0 to 672 (1 9 7 3 years:), J. Cherr li ca 1 S oc: ie 'ty ρ (3 r 1 (in r Γ ransactil ons I? 1199 to 1 20 1 (19 76), etc.); It is made by known methods such as catalytic reduction of 4-aminophenylarsinic acid.

314510.ptd 第 14 頁 200400165 五、發明說明(11) 又,依照本發明之方法所製得之反式-4 -胺基環己烷 羧酸或其鹽、或反式-4 -胺基環己烷羧酸之胺基保護衍生 物或其鹽做為原料化合物時,可按照下述方法製成一般式 [1 ]所示之DPP IV阻礙藥(參考國際公開2 0 0 2 - 3 0 8 9 1號公314510.ptd Page 14 200400165 V. Description of the invention (11) In addition, trans-4 -aminocyclohexanecarboxylic acid or a salt thereof, or trans-4 -amino ring obtained by the method of the present invention When an amine-protected derivative of hexanecarboxylic acid or a salt thereof is used as a raw material compound, a DPP IV inhibitory drug represented by the general formula [1] can be prepared according to the following method (refer to International Publication 2 0 0 2-3 0 8 9 Number 1

NC (式中,A示-CH2-或-S-,R示式( N—— 、、一 / 所示之(1 )可具有取代基之單環、雙環或三環含氮雜環 基,或(2)可具有取代基之胺基) 例如將依照本發明方法所製得之反式-4 -胺基環己烷 羧酸或其鹽,或反式-4 -胺基環己烷羧酸之胺基保護衍生 物或其鹽,和一般式[2 ]所示化合物或其鹽反應(例如縮合 劑共存下), R-Η [2] (式中,R示前述相同意義) 必要時,可將胺基之保護基去除而製成一般式[3 ]所 示化合物或其鹽, 、Η R'mII,,,,,{Z^NH2 〔3〕 〇NC (wherein A represents -CH2- or -S-, and R represents formula (N—— ,, (a) (1) may have a monocyclic, bicyclic or tricyclic nitrogen-containing heterocyclic group which may have a substituent, Or (2) an amine group which may have a substituent) For example, trans-4 -aminocyclohexanecarboxylic acid or a salt thereof, or trans-4 -aminocyclohexanecarboxylic acid prepared according to the method of the present invention The amine-protected derivative of an acid or a salt thereof is reacted with a compound represented by the general formula [2] or a salt thereof (for example, in the presence of a condensing agent), R-Η [2] (where R represents the same meaning as above), if necessary The compound of the general formula [3] or a salt thereof can be removed by removing the protecting group of the amine group, and R'mII ,,,,, {Z ^ NH2 [3].

314510.ptd 第15頁 200400165 五、發明說明(12) ^~__ (式中’ R示上述相同意義) 再將該一般式[3 ]所示化合物 示化合物反應(例如在去酸劑之共存二鹽,和一般式[4 ]所 要而將生成物轉變成藥理上容許、子或不存在下),並視需 示化合物或其藥理上容許之鹽(夂i而製成一般式[1 ]所 硤A韶、。 η | $考國際公開2 0 0 2 - 3 0 8 9 1 Ζ - (¾ 一 C — Ν ΧΑ314510.ptd Page 15 200400165 V. Description of the invention (12) ^ ~ __ (where 'R shows the same meaning as above) Then the compound shown by the general formula [3] is reacted (for example, in the coexistence of a deacidifier) Salt and the general formula [4] to transform the product into pharmacologically acceptable, non-existent or non-existent), and show the compound or its pharmacologically acceptable salt (夂 i to make general formula [1] as required)硖 A Shao,. Η | $ 考 国际 发布 2 0 0 2-3 0 8 9 1 ZO-(¾ One C — Ν ΧΑ

NC 〔4〕 (式中’ Α示上述相同意義,ζ干、、车^ 乙不活性殘基。) 以下藉實施例更詳細地說明本於 在其範圍内。 本^明,但本發明不侷限 實施例1 將5 g之4 -胺基環己烷羧之順式.g』帘 (東牙化成工業公司製品,反式/順式異構物=15/85)和97% 之氫氧化鈉2.92g—起懸濁在5〇ml之反式 1 90°C下授掉24小時進行異構化反應。反應液冷卻至室 溫,加入100ml之水,使用l〇〇ml乙醚洗淨2次。再於冰冷 g加入7· 4ml之濃鹽酸進行中和,減壓蒸餾去除水分。所 零殘渣加入45ml之甲醇,濾除不溶物,減壓某餾去除甲 醇,所=粗製物用氯仿、-甲醇混合溶液洗淨,而得3 24g之NC [4] (In the formula, 'A represents the same meaning as above, and ζ, ^, and ^ are inactive residues.) The following examples are used to explain this in more detail. This example is clear, but the present invention is not limited to Example 1. 5 g of 4-aminocyclohexane carboxyl cis.g "curtain (product of Dongya Chemical Industry Co., Ltd., trans / cis isomer = 15 / 85) and 97% sodium hydroxide 2.92 g-suspended in 50 ml of trans-1 at 90 ° C for 24 hours for isomerization reaction. The reaction solution was cooled to room temperature, 100 ml of water was added, and washed twice with 100 ml of ether. Then, 7.4 ml of concentrated hydrochloric acid was added to the ice-cold g for neutralization, and water was distilled off under reduced pressure. 45 ml of methanol was added to the zero residue, insoluble matter was filtered off, and methanol was distilled off under reduced pressure. The crude product was washed with chloroform and -methanol mixed solution to obtain 3 24 g of

BB 4 -胺基%己烷羧酸(反式/順式異構物=8 6 /丨4 )之淡黃色結 ΰ 熔點:2 1 4至2 1 7°C (分解)。 又’所得4 -胺基壞己燒羧酸之反式和順式異構物之比BB 4-Amino yellow hexanecarboxylic acid (trans / cis isomer = 8 6 / 丨 4) light yellow knot ΰ Melting point: 2 1 4 to 2 1 7 ° C (decomposition). And the ratio of the trans and cis isomers of the 4-aminoamine

第16頁Page 16

Eli 314510.ptd 200400165 五、發明說明(13) 率係於轉換成4 -(苯曱氧基羰基胺基)環己烷羧酸後,依照 下列條件進行HPLC分析定量。 分離管:CAPCELL PAK C18 UG120(4.6x 150mm) 洗提液:乙腈/ 0 · 1%三氟乙酸(3 0 / 7 0 ) 流量:1 . 0 m 1 /分鐘 溫度:2 5°C 波長:2 1 0 n m 試料:1 m g / m 1 (洗提液) 反式異構物之滯留時間:1 2. 6分鐘。 順式異構物之滯留時間:1 3. 8分鐘。 實施例2 (1 )將1 g之4 -胺基環己烷羧酸之順式和反式異構物之 混合物(東京化成工業公司製品,反式/順式異構物=1 5 / 8 5 )和9 7 %之氫氧化鈉0 . 5 8 g—起懸濁在1 0 m 1之反式-萘烧 中,於外溫1 9 (TC下攪拌2 4小時進行異構化反應。冷卻至 室溫後,加入2 0 m 1之水至反應液中,用2 0 m 1之乙醚洗淨2 次。 (2 )於上述(1 )項所得水層中,在冰冷下以1小時滴加 1 . 4 3 g之苯曱氧基獄基氯,繼之,加入5 m 1之2 N之氫氧化納 水溶液。室溫下攪拌1小時,用20ml之乙醚洗淨該反應 液。水層用1 0%鹽酸調整為酸性(pH = 4),以氯仿萃取。有 機層用水飽和食鹽水洗淨,以無水乙酸納乾燥,蒸I留去除 溶劑,而得1 . 7 3 g之4 -(苯曱氧基羰基胺基)環己烷羧酸(反 式/順式異構物=9 6 / 4 )之無色結晶。Eli 314510.ptd 200400165 V. Description of the invention (13) The conversion rate is based on the conversion to 4-(phenylphenoxycarbonylamino) cyclohexanecarboxylic acid and then quantified by HPLC analysis according to the following conditions. Separation tube: CAPCELL PAK C18 UG120 (4.6x 150mm) Eluent: Acetonitrile / 0 · 1% trifluoroacetic acid (3 0/70) Flow rate: 1.0 m 1 / min Temperature: 2 5 ° C Wavelength: 2 10 nm sample: 1 mg / m 1 (eluent) Retention time of trans isomers: 12.6 minutes. Retention time of cis isomer: 13.8 minutes. Example 2 (1) A mixture of cis and trans isomers of 1 g of 4-aminocyclohexanecarboxylic acid (product of Tokyo Chemical Industry Co., Ltd., trans / cis isomer = 1 5/8) 5) and 97% sodium hydroxide 0.58 g-suspended in 10 m 1 of trans-naphthalene, and stirred at an external temperature of 19 (TC for 24 hours for isomerization). After cooling to room temperature, 20 m 1 of water was added to the reaction solution, and washed twice with 20 m 1 of diethyl ether. (2) In the water layer obtained in the above item (1), under ice-cooling for 1 hour 1.43 g of benzamyloxyhexyl chloride was added dropwise, followed by 5 m 1 of 2 N aqueous sodium hydroxide solution. The mixture was stirred at room temperature for 1 hour, and the reaction solution was washed with 20 ml of ether. Water The layer was adjusted to be acidic (pH = 4) with 10% hydrochloric acid, and extracted with chloroform. The organic layer was washed with saturated brine, dried over anhydrous sodium acetate, and distilled to remove the solvent to obtain 1.7 g of 4- (Benzyloxycarbonylamino) colorless crystals of cyclohexanecarboxylic acid (trans / cis isomer = 9 6/4).

314510.ptd 第17頁 200400165 五、發明說明(14) (3 )將上述(2 )項所得結晶用二異丙醚洗淨而得1 . 4 6 g 之4 -(苯曱氧基羰基胺基)環己烷羧酸(反式/順式異構物二 9 9 . 6 / 0 . 4 )之無色結晶。熔點:2 2 0至2 2 1°C。 ‘ 又,所得4 -(苯曱氧基羰基胺基)環己烷羧酸之反式和 .順式異構物之比率係按照上述實施例1所記載之相同條件 以HPLC分析定量。 實施例3 (1 )將2 g之4 -胺基環己烷羧酸之順式和反式異構物之 混合物(東京化成工業公司製品,反式/順式異構物=1 5 / •5 ),和9 7 %之氫氧化納1 . 1 5 g—起懸濁在2 0 m 1之反式-萘烧 中,於外溫1 9 0°C下攪拌2 4小時進行異構化反應。將反應 液冷卻至室溫,加入4 0 m 1之水,用5 0 m 1之乙醚洗淨2次。 (2 )於上述(1 )項所得水層中,在冰冷下加入6 . 1 7 g之 二第三丁基二碳酸酯,繼之,加入1 0 m 1之2 N之氫氧化鈉水 溶液。室溫下攪;拌一夜,反應液用5 0 m 1之乙醚洗淨。水層 用1 0辦句櫞酸水溶液調整為酸性(pH = 4),用氯仿萃取之。 有機層用水及飽和食鹽水洗淨,以無水乙酸納乾燥、蒸德 去除溶劑,而得3 . 2 8 g之4 -(第三丁氧基羰基胺基)環己烷 羧酸(反式/順式異構物二8 8 / 1 2 )之無色結晶。 ® ( 3 )將上述(2 )項所得結晶用二異丙醚洗淨,而得 • 2 . 1 7g之4-(第三丁氧基羰基胺基)環己烷羧酸(反式/順式 異構物二9 3 / 7 )之無色結晶。熔點:1 7 6至1 7 7°C。 又,所得4 -(第三丁氧基羰基胺基)環己烷羧酸之反式 和順式異構物之比率係按照下列條件以HPLC分析進行定314510.ptd Page 17 200400165 V. Description of the invention (14) (3) The crystal obtained in the above item (2) was washed with diisopropyl ether to obtain 1. 4 g of 4- (phenylfluorenyloxycarbonylamino) ) Colorless crystals of cyclohexanecarboxylic acid (trans / cis isomer di 99.6 / 0.4). Melting point: 2 2 0 to 2 2 1 ° C. In addition, the ratio of the trans and .cis isomers of the obtained 4- (phenylfluorenyloxycarbonylamino) cyclohexanecarboxylic acid was quantified by HPLC analysis under the same conditions as described in Example 1 above. Example 3 (1) A mixture of 2 g of cis and trans isomers of 4-aminocyclohexanecarboxylic acid (product of Tokyo Chemical Industry Co., Ltd., trans / cis isomer = 1 5 / • 5), and 97% sodium hydroxide 1. 15 g—suspended in 20 m 1 of trans-naphthalene, and stirred at an external temperature of 19 ° C. for 2 4 hours for isomerization. reaction. The reaction solution was cooled to room temperature, 40 m 1 of water was added, and washed with 50 m 1 of ether twice. (2) To the water layer obtained in the above item (1), 6.17 g of bis-tert-butyl dicarbonate was added under ice cooling, followed by 10 m 1 of 2 N sodium hydroxide aqueous solution. Stir at room temperature; stir overnight, and wash the reaction solution with 50 ml of diethyl ether. The water layer was adjusted to be acidic (pH = 4) with a 10% aqueous solution of citric acid, and extracted with chloroform. The organic layer was washed with water and saturated brine, dried over anhydrous sodium acetate, and the solvent was removed by distillation to obtain 3. 2 g of 4- (third-butoxycarbonylamino) cyclohexanecarboxylic acid (trans / Colorless crystals of the cis isomer di 8 8/1 2). ® (3) The crystal obtained in (2) above was washed with diisopropyl ether to obtain 2. 17 g of 4- (third butoxycarbonylamino) cyclohexanecarboxylic acid (trans / cis Colorless crystals of the formula isomer 2 3 3/7). Melting point: 176 to 17 ° C. The ratio of the trans and cis isomers of the obtained 4- (third-butoxycarbonylamino) cyclohexanecarboxylic acid was determined by HPLC analysis under the following conditions.

314510.ptd 第18頁 200400165 五、發明說明(15) 量。 分離管:CAPCELL PAK C18 UG 1 2 0 ( 4.6x 1 5 0mm) 洗提液:乙腈/pH2· 0磷酸水溶液( 2 5 / 7 5 ) 流量:1 · 0 m 1 /分解 溫度:2 5°C 波長:2 1 0 n m 試料·· 1 ιώ g / 1 m 1 (洗提液) 反式異構物之滯留時間:1 4 · 4分鐘 順式異構物之滯留時間·· 1 5. 4分鐘 實施例4 (1 )將1 g之4 -胺基環己烧魏酸之順式和反式異構物之 混合物(東京化成工業公司製品,反式/順式異構物=丨5 / 8 5 )和1 · 5 7 g之第三丁醇鉀一起懸濁在5 〇 m丨之對-曱基異丙 基笨中’於外溫i 6 or下攪拌丨〇小時進行異構化反應。反 應液冷部至室溫後加入5 〇 m 1之水,去除有機層,水層用 5ml之曱苯洗淨2次。 (2 )於上述(1 )項所得水溶液中,在冰冷下以2小時滴 加1 . 79g之笨甲氧基羰基氯和5· 3]111之2N氫氧化鈉水溶液。 滴加後在室溫下攪拌2小時,用5m 1之乙酸乙酯洗淨該反應 液。再加入曱醇’冰冷下以3 0分鐘滴加1 · 5 m 1之濃鹽酸。 直接搜掉1小時之後,濾取析出物,用水-曱醇混合液 ^水:甲醇=3 : 1 )洗淨後,通風乾燥而得1 . 22g之4-(苯甲 氧基裁基胺基)環己烷羰酸(反式/順式異構物=9 5 / 5 )之無 色結晶。314510.ptd Page 18 200400165 V. Description of the invention (15) Quantity. Separation tube: CAPCELL PAK C18 UG 1 2 0 (4.6x 1 50 mm) Eluent: Acetonitrile / pH2 · 0 phosphoric acid aqueous solution (2 5/7 5) Flow rate: 1 · 0 m 1 / Decomposition temperature: 2 5 ° C Wavelength: 2 1 0 nm Sample ·· 1 ιώ g / 1 m 1 (eluent) Retention time of trans isomers: 1 4 · 4 minutes Retention time of cis isomers · 1 5. 4 minutes Example 4 (1) A mixture of 1 g of 4-aminocyclohexanoic acid in cis and trans isomers (product of Tokyo Chemical Industry Corporation, trans / cis isomer = 5/8) 5) Suspend it together with 1.57 g of potassium tert-butoxide in 50 m of p-fluorenylisopropylbenzyl 'and stir at an external temperature of i 6 or 0 h for an isomerization reaction. After the reaction liquid-cooled part was brought to room temperature, 50 ml of water was added to remove the organic layer. The water layer was washed twice with 5 ml of toluene. (2) To the aqueous solution obtained in the above item (1), 1.79 g of benzylmethoxycarbonyl chloride and 5.3] 111 2N aqueous sodium hydroxide solution were added dropwise under ice-cooling over 2 hours. After the dropwise addition, the mixture was stirred at room temperature for 2 hours, and the reaction solution was washed with 5 ml of ethyl acetate. Furthermore, methanol 'was added dropwise under concentrated cooling for 1.5 minutes at a concentration of 1.5 ml of hydrochloric acid. After searching directly for 1 hour, the precipitate was collected by filtration, washed with water-methanol mixture ^ water: methanol = 3: 1), washed and dried in air to obtain 1.22 g of 4- (benzyloxyalkylamino) ) Colorless crystals of cyclohexanecarbonyl acid (trans / cis isomer = 9 5/5).

第19頁 200400165 五、發明說明(16) 又,所得4 -(苯曱氧基羰基胺基)環己烷羧酸之反式和 順式異構物之比率係依照上述實施例1所記載之相同條件 以HPLC分析定量。 實施例 5 (1 )按照上述實施例4 (1 )所示相同方法,但反應時間 改為1 6小時,進行4 _胺基環己烷羧酸之異構化反應。 (2 )按照上述實施例4 ( 2 )所示相同方法進行胺基保護 反應,而得4 -(苯曱氧基羰基胺基)環己烷羧酸(反式/順式 異構物=8 6 / 1 4 )之無色結晶。 # ( 3 )懸濁上述(2 )項所得結晶於1 0 0 m 1之二異丙醚中, 在外溫6 0°C下攪拌3 0分鐘。攪拌下冷卻至室溫後,濾取析 出物,用二異丙醚洗淨,而得1 3 . 7 g之4 -(苯曱氧基羰基胺 基)環己烷羧酸(反式/順式異構物=9 9 · 9 / 0 . 1 )之無色結 晶。熔點:2 2 2至2 2 4°C。 又,所得4 -(苯曱氧基羰基胺基)環己烷羧酸之反式和 順式異構物之比率係按照上述實施例1所記載之條件進行 HPLC分析定量。 產業上之利用可行性 依照本發明方法,可在短時間内簡便而高效率地製造 #純度之反式-4 -胺基環己烷羧酸類。 又,本發明中,異構化反應係在固態、液態之不拘一 系中進行,所以更能獲得高純度之反式異構物。又,本發 明中,於異構化反應後在所得生成物之胺基上加以保護 基,則獲得更高純度之反式異構物。Page 19, 200400165 V. Description of the invention (16) In addition, the ratio of the trans and cis isomers of the obtained 4- (phenylfluorenyloxycarbonylamino) cyclohexanecarboxylic acid is as described in Example 1 above. Quantitative analysis by HPLC under the same conditions. Example 5 (1) According to the same method as described in Example 4 (1) above, but the reaction time was changed to 16 hours, an isomerization reaction of 4-aminocyclohexanecarboxylic acid was performed. (2) The amine group protection reaction is performed according to the same method as shown in the above Example 4 (2) to obtain 4- (phenylphenyloxycarbonylamino) cyclohexanecarboxylic acid (trans / cis isomer = 8 6/1 4) colorless crystals. # (3) Suspend the crystal obtained in the above item (2) in 100 m 1 of bisisopropyl ether, and stir at an external temperature of 60 ° C for 30 minutes. After cooling to room temperature with stirring, the precipitate was collected by filtration and washed with diisopropyl ether to obtain 13.7 g of 4- (phenylfluorenyloxycarbonylamino) cyclohexanecarboxylic acid (trans / cis Color isomers of the formula isomer = 9 9 · 9 / 0.1). Melting point: 2 2 2 to 2 2 4 ° C. The ratio of the trans- and cis-isomers of the 4- (phenylfluorenyloxycarbonylamino) cyclohexanecarboxylic acid obtained was quantified by HPLC analysis under the conditions described in Example 1 above. Industrial feasibility According to the method of the present invention, #purity of trans-4 -aminocyclohexanecarboxylic acids can be easily and efficiently produced in a short time. Furthermore, in the present invention, the isomerization reaction is carried out in a solid or liquid form, so that trans-isomers with high purity can be obtained more. Further, in the present invention, a protective group is added to the amine group of the resulting product after the isomerization reaction, and a trans isomer having a higher purity can be obtained.

314510.ptd 第20頁 200400165 圖式簡單說明本案無圖式314510.ptd Page 20 200400165 Schematic description

314510.ptd 第21頁314510.ptd Page 21

Claims (1)

200400165 六、申請專利範圍 1 . 一種反式-4 -胺基環己烷羧酸或其鹽,或反式-4 -胺基 環己烷羧酸之胺基保護衍生物或其鹽之製法,其特徵 為將4 -胺基環己烷羧酸或其活性衍生物之順式異構 • 物,或順式和反式異構物之混合物,以選自氫氧化納 和烷醇鉀所構成群中之鹼加以處理,視需要可將所得 生成物之胺基加以保護基。 ' 2 . —種反式-4 -胺基環己烷羧酸或其鹽之製法,其特徵為 將4 -胺基環己烷羧酸或其活性衍生物之順式異構物, 或順式和反式異構物之混合物,用選自氫氧化納和坑 _醇鉀所構成群中之鹼處理者。 3 . —種反式-4 -胺基環己烷羧酸或其鹽之製法,其特徵為 將4 -胺基環己烷羧酸或其活性衍生物之順式異構物, 或順式和反式異構物之混合物,用選自氫氧化納和烧 醇鉀所構成群中之鹼處理,再將其生成物之胺基加以 保護基者。 4.如申請專利範圍第1項至第3項中任意一項之製法,其 中該鹼處理係隨反應之進行而在固態-液態之不均一系 條件下進行者。 5 ·如申請專利範圍第1項至第3項中任意一項之製法,其 ® 中該鹼處理係在由該處理所產生之反式-4 -胺基環己烷 ♦ 羧酸之鹽至少一部分以固態存在,且所產生之順式-4 -胺基環己烷羧酸之鹽不呈固態而以溶解或熔融狀態存 ^ 在之條件下進行者。 .6.如申請專利範圍第1項至第3項中任意一項之製法,其200400165 6. Scope of patent application 1. A method for preparing trans-4 -aminocyclohexanecarboxylic acid or a salt thereof, or an amino-protected derivative of trans-4 -aminocyclohexanecarboxylic acid or a salt thereof, It is characterized by cis isomer of 4-aminocyclohexanecarboxylic acid or its active derivative, or a mixture of cis and trans isomers, and is composed of sodium hydroxide and potassium alkoxide. The base in the group is treated, and the amine group of the resulting product may be protected as necessary. '2. —A method for preparing trans-4-aminocyclohexanecarboxylic acid or its salt, characterized in that it is a cis isomer of 4-aminocyclohexanecarboxylic acid or its active derivative, or cis A mixture of formula and trans isomers is treated with a base selected from the group consisting of sodium hydroxide and potassium alkoxide. 3. A method for preparing trans-4-aminocyclohexanecarboxylic acid or a salt thereof, which is characterized in that the cis isomer of 4-aminocyclohexanecarboxylic acid or its active derivative, or cis And trans isomers, treated with a base selected from the group consisting of sodium hydroxide and potassium alkoxide, and then protecting the amine group of the product. 4. The method according to any one of claims 1 to 3 in the scope of patent application, wherein the alkali treatment is performed under the conditions of heterogeneity of solid-liquid as the reaction proceeds. 5 · If any one of the claims 1 to 3 of the scope of the patent application method, in which the alkali treatment is in the trans-4 -amino cyclohexane produced by the treatment Some of them are in a solid state, and the generated cis-4-aminocyclohexanecarboxylic acid salt is not in a solid state and is carried out under the conditions of being dissolved or molten. .6. If the system of any one of items 1 to 3 of the scope of patent application, 314510.ptd 第22頁 200400165 六、申請專利範圍 中該鹼處理係在實施該處理之溫度下,由該處理所產 生之反式-4 -胺基環己烷羧酸之鹽之至少一部分以固態 存在,而且所生成之順式-4 -胺基環己烷羧酸之鹽不呈 固態而以溶解或熔融狀態存在之溶劑中進行者。 7. 如申請專利範圍第1項至第3項中任意一項之製法,其 中(i )該鹼係使用氫氧化鈉,其處理溫度係在1 70至2 4 0 °C範圍進行,或(i i )該鹼係使用烷醇鉀,其處理溫度 係在1 5 0至2 2 0°C範圍進行者。 8. 如申請專利範圍第1項至第3項中任意一項之製法,其 中該鹼處理係在選自二曱苯、均三曱基苯、曱基異丙 基苯、萘烷、萘、癸烷、十一碳烷、十二碳烷、十一 碳烯、聯苯、二乙二醇二曱醚、苯曱醚、二乙二醇二 乙醚、三乙二醇二曱醚、二苯基醚、三丁胺、三苯基 胺和其混合物之溶劑中進行者。 9. 如申請專利範圍第1項至第3項中任意一項之製法,其 中(i ),該鹼係使用氫氧化鈉,其處理係在沸點1 8 0°C 以上之溶劑中進行,或(i i )該鹼係使用烷醇鉀,其處 理係去沸點1 6 (TC以上之溶劑中進行者。 1 0 .如申請專利範圍第1項至第3項中任意一項之製法,其 中(i ),該鹼係使用氫氣化鈉,其處理係在選自萘烷、 萘、Η--碳烷、十二碳烷、十二碳烯、聯苯、二乙二 醇二乙醚、三乙二醇二曱醚、三丁胺、三苯基胺和其 混合物之溶劑中進行,或(i i )該驗係使用烧醇鉀,其 處理係在選自曱基異丙基笨、均三曱基苯、萘烷、314510.ptd Page 22 200400165 6. In the scope of the patent application, the alkali treatment is that at least a part of the salt of trans-4 -aminocyclohexanecarboxylic acid produced by the treatment is in a solid state at the temperature at which the treatment is performed. Exist, and the generated cis-4-aminocyclohexanecarboxylic acid salt is not in a solid state and is carried out in a solvent in a dissolved or molten state. 7. The manufacturing method of any one of items 1 to 3 of the scope of patent application, wherein (i) the alkali is sodium hydroxide, and the treatment temperature is in the range of 1 70 to 240 ° C, or ( ii) The alkali system uses potassium alkoxide, and the treatment temperature is performed in the range of 150 to 220 ° C. 8. The method according to any one of claims 1 to 3 in the scope of patent application, wherein the alkali treatment is selected from the group consisting of dibenzobenzene, mesitylene, cumene isopropylbenzene, decalin, naphthalene, Decane, undecane, dodecane, undecene, biphenyl, diethylene glycol dimethyl ether, phenyl ether, diethylene glycol diethyl ether, triethylene glycol dimethyl ether, diphenyl Ether, tributylamine, triphenylamine and mixtures thereof in a solvent. 9. For the method for preparing any one of items 1 to 3 of the scope of patent application, wherein (i), the alkali is sodium hydroxide, and the treatment is performed in a solvent having a boiling point of 180 ° C or more, or (Ii) The alkali system uses potassium alkoxide, and its treatment is carried out in a solvent with a boiling point of 16 (TC or more. 1). As in the method of any one of claims 1 to 3, ( i), the base system uses sodium hydride, and its treatment is selected from the group consisting of decalin, naphthalene, fluorene--carbane, dodecane, dodecene, biphenyl, diethylene glycol diethyl ether, triethyl Glycol dimethyl ether, tributylamine, triphenylamine, and mixtures thereof in a solvent, or (ii) the test system uses potassium alkoxide, and the treatment is selected from the group consisting of fluorenyl isopropylbenzyl, melamine Benzene, decalin, 314510.ptd 第23頁 200400165 六、申請專利範圍 萘、癸烧、十一碳烧、十二碳烧、十二碳烯、聯苯、 二乙二醇二曱醚、二乙二醇二乙醚、三乙二醇二曱 醚、二苯基醚、三丁胺、三苯基胺以及其混合物之溶 " 劑中進行者。 .1 1 .如申請專利範圍第1項至第3項中任意一項之製法,其 中該鹼係使用氫氧化鈉者。 1 2 .如申請專利範圍第1項至第3項中任意一項之製法,其 中驗係使用烧醇奸者。 1 3 .如申請專利範圍第1 2項之製法,其中該烷醇鉀係使用 _第三丁醇鉀者。 1 4 .如申請專利範圍第1項或第3項之製法,其中加至生成 物之胺基上之保護基係苯甲氧基戴基者。 1 5 .如申請專利範圍第1項或第3項之製法,其中加至生成 物之胺基上之保護基係第三丁氧基羰基者。314510.ptd Page 23 200400165 VI. Application scope of patents naphthalene, decane, eleven carbon, dodecyl, dodecene, biphenyl, diethylene glycol dimethyl ether, diethylene glycol diethyl ether, Triethylene glycol dimethyl ether, diphenyl ether, tributylamine, triphenylamine, and mixtures thereof. .1 1. The production method according to any one of claims 1 to 3 in the scope of patent application, wherein the alkali is sodium hydroxide. 1 2. If the method of applying any one of items 1 to 3 of the scope of the patent application, the experience is to use a burner. 13. The manufacturing method according to item 12 of the scope of patent application, wherein the potassium alkoxide is a third potassium butoxide. 14. If the method for applying item 1 or item 3 of the scope of patent application, wherein the protective group added to the amine group of the product is a benzyloxy group. 1 5. If the method for applying item 1 or item 3 of the scope of patent application, wherein the protective group added to the amine group of the product is the third butoxycarbonyl group. 314510.ptd 第24頁314510.ptd Page 24
TW92105567A 2002-03-18 2003-03-14 Process for preparing trans-4-aminocyclohexanecarboxylic acids TWI280232B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2002073454 2002-03-18

Publications (2)

Publication Number Publication Date
TW200400165A true TW200400165A (en) 2004-01-01
TWI280232B TWI280232B (en) 2007-05-01

Family

ID=28035239

Family Applications (1)

Application Number Title Priority Date Filing Date
TW92105567A TWI280232B (en) 2002-03-18 2003-03-14 Process for preparing trans-4-aminocyclohexanecarboxylic acids

Country Status (4)

Country Link
JP (1) JP4202269B2 (en)
AU (1) AU2003221404A1 (en)
TW (1) TWI280232B (en)
WO (1) WO2003078381A1 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105085296A (en) * 2015-09-09 2015-11-25 常州齐晖药业有限公司 Method for isomerizing intermediate for preparing trans-4-(boc-amino)cyclohexanecarboxylic acid
CN108290813A (en) * 2015-11-27 2018-07-17 住友化学株式会社 The manufacturing method of trans-cyclohexane formic acid

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4945040A (en) * 1972-09-08 1974-04-27
JPS5339419B2 (en) * 1972-10-19 1978-10-21
JPS57122062A (en) * 1981-01-22 1982-07-29 Nippon Chemiphar Co Ltd Novel trans-4-guanidinocyclohexanecarboxylic acid derivative and its preparation
US5831118A (en) * 1996-06-18 1998-11-03 Katayama Seiyakusyo Co., Ltd. Epimerization of 2- or 4- substituted cyclohexanecarboxylic acids
JP3009374B2 (en) * 1997-04-23 2000-02-14 長谷川香料株式会社 Method for producing trans-4-alkylcyclohexanecarboxylic acid esters

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105085296A (en) * 2015-09-09 2015-11-25 常州齐晖药业有限公司 Method for isomerizing intermediate for preparing trans-4-(boc-amino)cyclohexanecarboxylic acid
CN105085296B (en) * 2015-09-09 2017-08-08 常州齐晖药业有限公司 The method that one kind prepares trans 4 (t-butoxycarbonyl amino) cyclohexanecarboxylic acid intermediate isomerization
CN108290813A (en) * 2015-11-27 2018-07-17 住友化学株式会社 The manufacturing method of trans-cyclohexane formic acid

Also Published As

Publication number Publication date
AU2003221404A1 (en) 2003-09-29
JPWO2003078381A1 (en) 2005-07-14
JP4202269B2 (en) 2008-12-24
WO2003078381A1 (en) 2003-09-25
TWI280232B (en) 2007-05-01

Similar Documents

Publication Publication Date Title
US11952341B2 (en) Method of preparing high chiral purity lactam intermediate and brivaracetam
US20090036680A1 (en) Salts of hmg-coa reductase inhibitors and use thereof
KR101609898B1 (en) A process for preparing r-beta-amino phenylbutyric acid derivatives
EP3218351B1 (en) A method for the preparation, isolation and purification of pharmaceutically applicable forms of ahu-377
CN107001359B (en) process for preparing praziquantel and precursors thereof
EP2980090A1 (en) Method for producing (1s,4s,5s)-4-bromo-6-oxabicyclo[3.2.1]octan-7-one
WO2014023576A1 (en) Process for the preparation of 2-cyanophenylboronic acid and esters thereof
JP2013543884A (en) Manufacturing method for high-purity pharmaceutical intermediates
KR20170032328A (en) Pyrazole derivative manufacturing method
JP2016531925A (en) Intermediate production method for pemetrexed production and method for producing high purity pemetrexed using the same
BG107478A (en) Process for the crystallization of losartan potassium
JP2001322979A (en) Method for producing 3-bromoquinoline
JP2019108351A (en) Methods for producing molindone and its salts
BG65699B1 (en) Process for the synthesis of a tetrazol derivative
TW200400165A (en) Process for preparing trans-4-aminocylcohexanecarboxylic acids
HU229188B1 (en) Process for the preparation of n-[(s)-1-carboxybutyl]-(s)-alanine esters and their use for synthesizing perindopril
TW202120470A (en) Process for the preparation of a nitric oxide donating prostaglandin analogue
HU202826B (en) Process for producing (2,6-dichloro-phenyl)-amino-phenyl-acetic acid derivatives
RU2387641C2 (en) Novel crystalline form of perindopril
WO2010122682A1 (en) PROCESS FOR PRODUCTION OF N-ALKOXYCARBONYL-tert-LEUCINES
WO2011026349A1 (en) Dipeptide boronic acid containing β-amino acid and carboxylic acids, its ester compounds, preparation method and use thereof
WO2007052296A2 (en) A process of preparing amorphous atorvastatin calcium
EP1564209A1 (en) Process for the preparation of 13-cis-retinoic acid
EP1849777B1 (en) Process for obtaining a valsartan salt useful for obtaining valsartan
HU203540B (en) Process for producing 1-propargyl-2,4-dioxo-imidazolidine

Legal Events

Date Code Title Description
MM4A Annulment or lapse of patent due to non-payment of fees